Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”

Yuanbin Liu ,  Mingkai Chen

Clinical and Molecular Hepatology

2023 .01

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?

Ho Soo Chun ,  Minjong Lee

Clinical and Molecular Hepatology

2023 .04

A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease

Seonghwan Hwang ,  Won Kim

Clinical and Molecular Hepatology

2022 .07

Personalized medicine in nonalcoholic fatty liver disease

Ca ,  los J. Pi ,  ola 외 1명

Clinical and Molecular Hepatology

2022 .10

Reply to Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”

Seung Min Lee ,  Dae Won Jun

Clinical and Molecular Hepatology

2023 .01

Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways

Seung Min Lee ,  Dong Hee Koh ,  Dae Won Jun 외 4명

Clinical and Molecular Hepatology

2022 .10

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?

Ma ,  ga ,  et LP Teng 외 4명

Clinical and Molecular Hepatology

2023 .04

Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?

Hyuk Soo Eun

Clinical and Molecular Hepatology

2020 .01

Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology

Yoon ,  In Cheol ,  Eun 외 1명

영남의대학술지

2019 .01

Alleviating lysosomal impairment in macrophages mitigates the progression of nonalcoholic steatohepatitis

Seyeon Joo ,  Sungsoon Fang

한국실험동물학회 학술발표대회 논문집

2025 .02

Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease

노정현

Journal of Obesity & Metabolic Syndrome

2020 .01

Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials

Jihyun An ,  Joo Hyun Sohn

Clinical and Molecular Hepatology

2023 .02

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease

Ji-Won Pa ,  k ,  Ki Tae Suk

Clinical and Molecular Hepatology

2023 .04

Experimental liver injury and nonalcoholic steatohepatitis animal models

Mohammed A. Alshawsh

한국실험동물학회 학술발표대회 논문집

2019 .07

The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease

Lee Ji Yeon

Gut and Liver

2024 .07

비알코올성 지방간염의 진단

유정주 ,  김상균

대한내과학회지

2018 .01

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments

Sang Bong Ahn

Clinical and Molecular Hepatology

2023 .02

Correlation between Transient Elastography (Fibroscan®) and Ultrasonographic and Computed Tomographic Grading in Pediatric Nonalcoholic Steatohepatitis

Ji Eun Lee ,  Kyung Ok Ko ,  Jae Woo Lim 외 3명

Pediatric Gastroenterology, Hepatology & Nutrition

2022 .05

The Immune Landscape in Nonalcoholic Steatohepatitis

Sowmya Na ,  ayanan ,  Fionna A. Su 외 2명

Immune Network

2016 .06

Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations

Soon Sun Kim ,  Jae Youn Cheong

Clinical and Molecular Hepatology

2022 .10